Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB290157 trifluoroacetate is a potent and selective antagonist of C3a receptor(IC50 of 200 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 74.00 | |
25 mg | In stock | $ 163.00 | |
50 mg | In stock | $ 278.00 | |
100 mg | In stock | $ 488.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 60.00 |
Description | SB290157 trifluoroacetate is a potent and selective antagonist of C3a receptor(IC50 of 200 nM). |
Targets&IC50 | C3a:200 nM |
In vitro | SB 290157 is a competitive antagonist of 125I-C3a radioligand binding to rat basophilic leukemia-2H3 cells expressing the human C3aR (RBL-C3aR, IC50 of 200 nM). SB 290157 blocks C3a-induced C3aR internalization in a concentration-dependent manner and C3a-induced Ca2+ mobilization in RBL-C3aR cells and human neutrophils (IC50s of 27.7 and 28 nM, respectively). SB 290157 is selective for the C3aR in that. SB 290157 also inhibits C3a-induced Ca2+ mobilization of RBL-2H3 cells expressing the mouse and guinea pig C3aRs. It potently inhibits C3a-mediated ATP release from guinea pig platelets and inhibits C3a-induced potentiation of the contractile response to field stimulation of perfused rat caudal artery[1]. |
In vivo | SB 290157 effectively inhibits neutrophil recruitment in a guinea pig model of LPS-induced airway neutrophilia and reduces paw edema in a rat model of adjuvant-induced arthritis. This antagonist demonstrates a capacity to decrease joint swelling, achieving approximately 50% inhibition at a concentration of 30 mg/kg, but only at the 3-hour mark. Additionally, it significantly lowers C3 levels at 3 hours post-administration, indicating complement consumption compared to naive mice. An increase in C3 activation correlates with the graded concentration of anti-OVA pAb, further showcasing its biological activity (1, 2). |
Molecular Weight | 526.51 |
Formula | C24H29F3N4O6 |
CAS No. | 1140525-25-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (237.41 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SB290157 trifluoroacetate 1140525-25-2 Immunology/Inflammation Complement System SB290157 Trifluoroacetate SB290157 SB-290157 trifluoroacetate Inhibitor SB 290157 Trifluoroacetate inhibit SB 290157 SB-290157 SB-290157 Trifluoroacetate inhibitor